Integral Diagnostics Limited's (ASX:IDX) Top Owners Are Retail Investors With 50% Stake, While 44% Is Held by Institutions
Top Broker Bullish on These Beaten Down ASX Shares
2 ASX Small-cap Shares to Buy With Big Potential
Integral Diagnostics Raised to Buy From Neutral by Citigroup >IDX.AU
Investors Shouldn't Be Too Comfortable With Integral Diagnostics' (ASX:IDX) Earnings
Don't Buy Integral Diagnostics Limited (ASX:IDX) For Its Next Dividend Without Doing These Checks
Are Poor Financial Prospects Dragging Down Integral Diagnostics Limited (ASX:IDX Stock?
Canaccord Genuity Upgrades Integral Diagnostics to Buy From Hold; Price Target Is AU$2.90
Bell Potter Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Price Target Cut 7.4% to A$3.15/Share by Barrenjoey
Integral Diagnostics Ltd To Go Ex-Dividend On March 6th, 2025 With 0.025 AUD Dividend Per Share
Integral Diagnostics Ltd (ASX:IDX) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...
This ASX Healthcare Stock Is Crashing 30% on Half Year Results
Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises
Integral Diagnostics Ltd: FY25 Half Year Results Investor Presentation
Integral Diagnostics Interim Dividend 2.5 Australian Cents/Security
Integral Diagnostics Ltd: FY25 Half Year Results Media Release
Integral Diagnostics Ltd: FY25 Half Year Results App4D and Interim Report
Which ASX 200 Healthcare Share Will Pay the Best Dividend Yield in 2025?
Integral Diagnostics Ltd. Appoints New Director to Strengthen Leadership